...
首页> 外文期刊>The biochemical journal >Regulation of polyribosome formation and protein synthesis in the uterus. Effect of administration of graded doses of oestradiol-17β and actinomycin D on the amino acid-incorporation activity in vitro and the cytoplasmic concentration in vivo of polyribosomes
【24h】

Regulation of polyribosome formation and protein synthesis in the uterus. Effect of administration of graded doses of oestradiol-17β and actinomycin D on the amino acid-incorporation activity in vitro and the cytoplasmic concentration in vivo of polyribosomes

机译:子宫中多核糖体形成和蛋白质合成的调节。渐进剂量的雌二醇-17β和放线菌素D对多核糖体的体外氨基酸掺入活性和体内细胞质浓度的影响

获取原文

摘要

p1. The effects of graded doses of oestradiol-17β and actinomycin D, administered separately or together, on the amino acid-incorporation activity iin vitro/i and the cytoplasmic concentration iin vivo/i of uterine polyribosomes are described. Preparations of polyribosomes isolated from uteri of ovariectomized adult rats were determined for cytoplasmic concentration iin vivo/i and assayed for [sup14/supC]leucine-incorporation activity in the cell-free system, exactly as described by Teng & Hamilton (1967ib/i). 2. A minimal dose of 10μg of oestradiol-17β administered for 10h was found to increase, by about 100%, both the amino acid-incorporation activity iin vitro/i and the cytoplasmic concentration iin vivo/i of the polyribosomes. A minimal dose of 250μg of actinomycin D administered for 10h was found to inhibit, by about 50%, the incorporation activity iin vitro/i of the polyribosomes. All doses of the inhibitor administered for 10h failed to alter the cytoplasmic concentration iin vivo/i of the polyribosomes. 3. A dose of 10μg of oestradiol-17β restored to the control value the inhibitory effect of a dose of either 50 or 125μg of actinomycin D on the activity iin vitro/i of the polyribosomes, at 10h after treatment with the inhibitor and the hormone. In these experiments, there was an increase of 60–100% in the cytoplasmic concentration iin vivo/i of the polyribosomes. 4. A dose of 125μg of actinomycin D, administered to animals along with 10μg of oestradiol-17β for 6–36h, abolished the hormone-induced enhancement of the incorporation activity iin vitro/i, but did not prevent an increase of about 200% in the cytoplasmic concentration iin vivo/i of the polyribosomes. However, treatment with 750μg of the inhibitor abolished both stimulatory effects of the hormone. 5. The results reported indicate that the stimulatory effects of oestradiol-17β iin vivo/i on the number and activity of the cytoplasmic polyribosomes in the uterus of the ovariectomized rat have different sensitivities to actinomycin D, but the primary molecular mechanisms responsible for the results are unknown. The major conclusion drawn is that the formation and appearance in the cytoplasm of newly formed polyribosomes are important features of the early action of oestrogen in the uterus./p
机译:> 1。渐进剂量的雌二醇17β和放线菌素D单独或一起给药对子宫多核糖体的体外氨基酸掺入活性和体内细胞质浓度的影响描述。测定从卵巢切除的成年大鼠子宫中分离的多核糖体制剂的体内细胞质浓度,并在无细胞系统中准确测定[ 14 C]亮氨酸掺入活性就像腾& amp;汉密尔顿(1967 b )。 2.发现最低剂量的10μg雌二醇17β给药10h,可使体外氨基酸掺入活性和体内细胞质浓度均提高约100%。 / i>多核糖体。发现最小剂量的250μg放线菌素D施用10h可抑制多核糖体的体外掺入活性约50%。施用10h的所有剂量的抑制剂都无法改变多核糖体内的细胞质浓度。 3.剂量为10μg的雌二醇17β恢复至对照值,即在用HCV处理10h后,放线菌素D剂量对多核糖体的体外抑制作用为50或125μg。抑制剂和激素。在这些实验中,多核糖体的体内细胞质浓度增加了60-100%。 4.与动物一起服用125μg放线菌素D和10μg雌二醇17β持续6–36h,可以消除激素诱导的体外结合活性的增强,但并不能阻止多核糖体的体内细胞质浓度增加约200%。但是,用750μg抑制剂治疗后,激素的两种刺激作用都消失了。 5.报道的结果表明,雌二醇17β体内刺激对去卵巢大鼠子宫中胞质多核糖体的数量和活性的影响对放线菌素D的敏感性不同,但主要分子造成结果的机制尚不清楚。得出的主要结论是,新形成的多核糖体在细胞质中的形成和出现是子宫内雌激素早期作用的重要特征。

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号